Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?

Por Blasi, F., Canonica, G. W., Miravitlles, M.
Publicado no Respir Res (2017)

Erratum to: Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?

Por Blasi, F., Canonica, G. W., Miravitlles, M.
Publicado no Respir Res (2017)

The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis

Por Miravitlles M, Chapman KR, Chuecos F, Ribera A, Garcia Gil E
Publicado em 2016-08-01

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

Por Brusasco, V, Hodder, R, Miravitlles, M, Korducki, L, Towse, L, Kesten, S
Publicado em 2003

Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

Por Brusasco, V, Hodder, R, Miravitlles, M, Korducki, L, Towse, L, Kesten, S
Publicado em 2006

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease

Por Miravitlles M, Price D, Rabe KF, Schmidt H, Metzdorf N, Celli B
Publicado em 2015-03-01

Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD

Por Miravitlles M, Marín A, Huerta A, Carcedo D, Villacampa A, Puig-Junoy J
Publicado em 2020-07-01

Alpha‐1‐antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics

Por Soy, D, de la Roza, C, Lara, B, Esquinas, C, Torres, A, Miravitlles, M
Publicado em 2006

Diaphragmatic Movement at Rest and After Exertion: A Non-Invasive and Easy to Obtain Prognostic Marker in COPD

Por Mekov E, Yanev N, Kurtelova N, Mihalova T, Tsakova A, Yamakova Y, Miravitlles M, Petkov R
Publicado em 2022-05-01

Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update

Por Blanco I, Bueno P, Diego I, Pérez-Holanda S, Casas-Maldonado F, Esquinas C, Miravitlles M
Publicado em 2017-02-01

Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease

Por Sethi, S., Anzueto, A., Miravitlles, M., Arvis, P., Alder, J., Haverstock, D., Trajanovic, M., Wilson, R.
Publicado no Infection (2015)

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment

Por Aisanov Z, Avdeev S, Arkhipov V, Belevskiy A, Chuchalin A, Leshchenko I, Ovcharenko S, Shmelev E, Miravitlles M
Publicado em 2018-01-01

Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach

Por Belmonte I, Barrecheguren M, López-Martínez RM, Esquinas C, Rodríguez E, Miravitlles M, Rodríguez-Frias F
Publicado em 2016-10-01

Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide

Por Blanco I, Bueno P, Diego I, Pérez-Holanda S, Lara B, Casas-Maldonado F, Esquinas C, Miravitlles M
Publicado em 2017-06-01

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK

Por Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC
Publicado em 2015-10-01

Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for respon...

Por Rodrigo, M J, Miravitlles, M, Cruz, M J, de Gracia, J, Vendrell, M, Pascual, C, Morell, F
Publicado em 1997

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study [Corrigendum]

Por Casas A, Montes de Oca M, Menezes AMB, Wehrmeister FC, Lopez Varela MV, Mendoza L, Ramírez L, Miravitlles M
Publicado em 2019-01-01

Screening for polymorphisms in exon 5 of the glutathione S-transferase Pl gene

Por RODRIGUEZ-FRIAS, F., GONZALEZ, C., COSTA, X., CAMPOS, F., COTRINA, M., JARDI, R., MIRAVITLLES, M., VIDAL, R., ISHII, T., TERAMOTO, S., MATSUSE, T.
Publicado em 2000

Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study

Por Miravitlles, M, Ferrer, M, Pont, A, Zalacain, R, Alvarez-Sala, J, Masa, F, Verea, H, Murio, C, Ros, F, Vidal, R
Publicado em 2004

Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East–North Africa reg...

Por Mahboub BH, Vats MG, Al Zaabi A, Iqbal MN, Safwat T, Al-Hurish F, Miravitlles M, Singh D, Asad K, Zeineldine S, Al-Hajjaj MS
Publicado em 2017-10-01